A broken filter: prefrontal functional connectivity abnormalities in schizophrenia during working memory interference
- PMID: 22863548
- PMCID: PMC3879404
- DOI: 10.1016/j.schres.2012.07.007
A broken filter: prefrontal functional connectivity abnormalities in schizophrenia during working memory interference
Abstract
Characterizing working memory (WM) abnormalities represents a fundamental challenge in schizophrenia research given the impact of cognitive deficits on life outcome in patients. In prior work we demonstrated that dorsolateral prefrontal cortex (DLPFC) activation was related to successful distracter resistance during WM in healthy controls, but not in schizophrenia. Although understanding the impact of regional functional deficits is critical, functional connectivity abnormalities among nodes within WM networks may constitute a final common pathway for WM impairment. Therefore, this study tested the hypothesis that schizophrenia is associated with functional connectivity abnormalities within DLPFC networks during distraction conditions in WM. 28 patients and 24 controls completed a delayed non-verbal WM task that included transient visual distraction during the WM maintenance phase. We computed DLPFC whole-brain task-based functional connectivity (tb-fcMRI) specifically during the maintenance phase in the presence or absence of distraction. Results revealed that patients failed to modulate tb-fcMRI during distracter presentation in both cortical and sub-cortical regions. Specifically, controls demonstrated reductions in tb-fcMRI between DLPFC and the extended amygdala when distraction was present. Conversely, patients failed to demonstrate a change in coupling with the amygdala, but showed greater connectivity with medio-dorsal thalamus. While controls showed more positive coupling between DLPFC and other prefrontal cortical regions during distracter presentation, patients failed to exhibit such a modulation. Taken together, these findings support the notion that observed distracter resistance deficit involves a breakdown in coupling between DLPFC and distributed regions, encompassing both subcortical (thalamic/limbic) and control region connectivity.
Published by Elsevier B.V.
Conflict of interest statement
John H. Krystal, MD 2012 financial disclosure.
Note: the individual consultant agreements listed below are less than $10,000 per year.
Consultant
Aisling Capital, LLC
Astellas Pharma Global Development, Inc.
AstraZeneca Pharmaceuticals
Biocortech
Brintnall & Nicolini, Inc.
Easton Associates
Gilead Sciences, Inc.
GlaxoSmithKline
Janssen Pharmaceuticals
Lundbeck Research USA
Medivation, Inc.
Merz Pharmaceuticals
MK Medical Communications
F. Hoffmann-La Roche Ltd
Sage Therapeutics, Inc.
SK Holdings Co., Ltd
Sunovion Pharmaceuticals, Inc.
Takeda Industries
Teva Pharmaceutical Industries, Ltd.
Scientific Advisory Board
Abbott Laboratories
Bristol-Myers Squibb
CHDI Foundation, Inc.
Eisai, Inc.
Eli Lilly and Co.
Forest Laboratories, Inc.
Lohocla Research Corporation
Mnemosyne Pharmaceuticals, Inc.
Naurex, Inc.
Pfizer Pharmaceuticals
Shire Pharmaceuticals
StratNeuro Research Program at Karolinska Institute (International Advisory Board)
Board of Directors
Coalition for Translational Research in Alcohol and Substance Use Disorders
President
American College of Neuropsychopharmacology
Income greater than $10,000
Editorial Board
Editor - Biological Psychiatry
Employment
Yale University School of Medicine
VA CT Healthcare System
Patents and inventions
Seibyl JP, Krystal JH, Charney DS. Dopamine and noradrenergic reuptake inhibitors in treatment of schizophrenia. Patent #:5,447,948.September 5, 1995
I am a co-inventor with Dr. Gerard Sanacora on a filed patent application by Yale University related to targeting the glutamatergic system for the treatment of neuropsychiatric disorders (PCTWO06108055A1).
Intranasal administration of ketamine to treat depression (pending)
Figures
References
-
- Andreasen NC. The scale for the assessment of negative symptoms (SANS) University of Iowa, Iowa City; 1983a.
-
- Andreasen NC. The scale for the assessment of positive symptoms (SAPS) University of Iowa, Iowa City; 1983b.
-
- Anticevic A, Repovs G, Corlett PR, Barch DM. Negative and Non-emotional Interference with Visual Working Memory in Schizophrenia. Biol Psychiatry. 2011a;70 (12):1159–1168. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
